Literature DB >> 2830888

An investigation of the beta-adrenoceptor that mediates metabolic responses to the novel agonist BRL28410 in rat soleus muscle.

R A Challiss1, B Leighton, S Wilson, P L Thurlby, J R Arch.   

Abstract

The beta-adrenoceptor agonist BRL26830A selectively stimulates metabolic rate in the rat and this thermic effect is resistant to blockade by propranolol. These effects of BRL26830A are partly due to selective stimulation by its metabolite BRL28410, of brown adipocyte beta-adrenoceptors, these receptors being resistant to propranolol. To investigate whether the metabolic effects of BRL28410 in skeletal muscle are also mediated by atypical beta-adrenoceptors, the potencies of BRL28410 and isoprenaline were compared for beta-adrenoceptor mediated responses in rat stripped soleus muscle. In addition, pA2 values for antagonism by propranolol of these responses were determined. Isoprenaline had similar EC50 values for stimulation of lactate formation (4.3 X 10(-9) M) and inhibition of glycogen synthesis (3.4 X 10(-9) M) and these values are similar to its reported EC50 values for stimulation of atrial rate (beta 1-adrenoceptor-mediated) and relaxation of the uterus (beta 2-adrenoceptor-mediated). BRL28410 had similar EC50 values for stimulation of lactate formation (3.7 X 10(-6) M) and inhibition of glycogen synthesis (3.8 X 10(-6) M). These values are only about two-fold less than reported values for relaxation of the uterus, but ten-fold less than reported values for stimulation of atrial rate. The pA2 value of dl-propranolol for antagonism of the effect of isoprenaline on glycogen synthesis (8.38 +/- 0.13) was in the range expected for beta 1- or beta 2-adrenoceptors, but with BRL28410 as agonist the pA2 value was about one unit lower (7.39 +/- 0.11). The beta-adrenoceptors that mediate the metabolic effects of BRL28410 in soleus muscle therefore differ from those that mediate atrial rat, uterine relaxation and adipocyte lipolysis. In addition, the low pA2 value of dl-propranolol versus BRL28410 in rat soleus muscle, which contrasts with the normal pA2 value previously reported for guinea-pig trachea, suggests that beta 2-adrenoceptors in these two tissues can be differentiated with suitable pharmacological agents.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2830888     DOI: 10.1016/0006-2952(88)90186-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  20 in total

Review 1.  The beta 3-adrenergic system and beta 3-adrenergic agonists.

Authors:  J R Arch
Journal:  Rev Endocr Metab Disord       Date:  2001-10       Impact factor: 6.514

Review 2.  Biotechnology of beta-adrenergic receptors.

Authors:  A D Strosberg
Journal:  Mol Neurobiol       Date:  1990 Fall-Winter       Impact factor: 5.590

Review 3.  Multiple actions of beta-adrenergic agonists on skeletal muscle and adipose tissue.

Authors:  Y T Yang; M A McElligott
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

4.  Antihyperglycemic action of isoferulic acid in streptozotocin-induced diabetic rats.

Authors:  I M Liu; F L Hsu; C F Chen; J T Cheng
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

5.  Biphasic effects of the beta-adrenoceptor agonist, BRL 37344, on glucose utilization in rat isolated skeletal muscle.

Authors:  Y L Liu; M A Cawthorne; M J Stock
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

6.  Characterization of catecholamine-mediated relaxations in rat isolated gastric fundus: evidence for an atypical beta-adrenoceptor.

Authors:  D P McLaughlin; A MacDonald
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

7.  Acute effects of the beta 3-adrenoceptor agonist, BRL 35135, on tissue glucose utilisation.

Authors:  Y L Liu; M J Stock
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

8.  Adrenergic pathway activation enhances brown adipose tissue metabolism: a [¹⁸F]FDG PET/CT study in mice.

Authors:  M Reza Mirbolooki; Sanjeev Kumar Upadhyay; Cristian C Constantinescu; Min-Liang Pan; Jogeshwar Mukherjee
Journal:  Nucl Med Biol       Date:  2013-10-01       Impact factor: 2.408

9.  Characterization of propranolol-resistant (-)-[125I]-cyanopindolol binding sites in rat soleus muscle.

Authors:  S J Roberts; P Molenaar; R J Summers
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

10.  Anaerobic orbital cellulitis: a clinical and experimental study.

Authors:  M S Jedrzynski; J D Bullock; T W McGuire; B L Elder; J D Bullock
Journal:  Trans Am Ophthalmol Soc       Date:  1991
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.